Shares of Snowflake ( SNOW) gained about 3% Monday afternoon as Wedbush upgraded the stock, saying the cloud software ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after ...

Wedbush has assumed coverage of Voyager Therapeutics (VYGR) with an outperform rating, highlighting the company’s TRACER ...

Apple's new iPhone 16 is off to a strong start, with positive demand globally and upcoming AI features set to drive sales ...

Gerber has grown skeptical of Musk's other ventures in recent years, and has said previously that his side projects are ...

Jared Cohen, Goldman Sachs president of global affairs, co-head of the Goldman Sachs Global Institute, said while talking to ...

Wedbush notes that in the past two weeks Kioxia filed for an IPO and SanDisk released its 10-12B, telling investors that data from these ...

We recently published a list of 15 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

Microsoft stock was lagging behind its tech peers on Friday as investors reacted to news the company is facing a broad ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Closing Bell: Overtime' to discuss regulatory risks for tech, why he's bullish on Tesla as an artificial intelligence ...

Fintel reports that on November 25, 2024, Wedbush upgraded their outlook for Snowflake (NYSE:SNOW) from Neutral to Outperform ...